CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Starling Oncology, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Starling Oncology, Inc.
18000 Studebaker Rd, Suite 800
Phone: (562) 735-3226p:562 735-3226 CERRITOS, CA  90703  United States Ticker: STLNSTLN
Business Summary
Starling Oncology, Inc., formerly The Oncology Institute, Inc., is advancing oncology by delivering specialized, value-based cancer care in the community setting. The Company offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with oncology organizations. Its critical services include cancer treatment and infusion centers, in-house dispensary, lab testing, outpatient blood transfusion, financial counseling, end-of-life counseling and comprehensive clinical trials. It treats many forms of cancer, including Acute lymphoblastic leukemia; Acute myeloid leukemia; Bladder cancer; Bone cancer; Brain cancer; Cervical cancer; Choriocarcinoma; Chronic lymphocytic leukemia (CLL); Chronic myeloid leukemia (CML); Skin cancer, and others. It operates over 100 clinics and affiliate locations across multiple states.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202612/31/2025YesYes--Yes

Industries
SIC Code Description
8011 Offices and clinics of doctors of medicine
8093 Specialty outpatient facilities, not elsewhere classified
8099 Health and allied services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board AnneMcgeorge 65 8/12/2025 11/1/2021
Chief Executive Officer, Director DanielVirnich 47 6/30/2023 6/30/2023
Independent Vice Chairman of the Board BradHively 47 6/30/2023 11/1/2021
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Broward Oncology Associates LLC 6405 N Federal Hwy # 300B Fort Lauderdale FL United States
Oncology Association 4700 Habana Way Tampa FL United States

Business Names
Business Name
Broward Oncology Associates LLC
DFP Healthcare Acquisitions Corp.
DFPH
9 additional Business Names available in full report.

General Information
Number of Employees: 641 (As of 12/31/2025)
Outstanding Shares: 100,468,979 (As of 6/30/2026)
Shareholders: 35
Stock Exchange: NASD
Fax Number: (302) 636-5454


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, August 16, 2026